Monday, 17 December 2012

Evidence for Sativex reviewed

Source MS Trust:

Sativex is a cannabis-based medicine which was licensed in June 2010 as a treatment for spasticity in MS. A review in the December 2012 issue of Drug and Therapeutics Bulletin (DTB) has suggested there is not enough evidence to support the use of Sativex routinely in treating spasticity in MS.  Read more here!